| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1242 | 2019 |
| A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 663 | 2009 |
| Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae MJ Schwaber, S Navon-Venezia, KS Kaye, R Ben-Ami, D Schwartz, ... Antimicrobial agents and chemotherapy 50 (4), 1257-1262, 2006 | 589 | 2006 |
| Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel D Mevorach, E Anis, N Cedar, M Bromberg, EJ Haas, E Nadir, ... New England Journal of Medicine 385 (23), 2140-2149, 2021 | 532 | 2021 |
| Influx of extended-spectrum β-lactamase—producing Enterobacteriaceae into the hospital R Ben-Ami, MJ Schwaber, S Navon-Venezia, D Schwartz, M Giladi, ... Clinical infectious diseases 42 (7), 925-934, 2006 | 454 | 2006 |
| Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting S Navon-Venezia, R Ben-Ami, Y Carmeli Current opinion in infectious diseases 18 (4), 306-313, 2005 | 407 | 2005 |
| Multidrug-resistant candida haemulonii and C. Auris, tel aviv, Israel R Ben-Ami, J Berman, A Novikov, E Bash, Y Shachor-Meyouhas, S Zakin, ... Emerging infectious diseases 23 (2), 195, 2017 | 333 | 2017 |
| Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study RE Lewis, L Cahyame‐Zuniga, K Leventakos, G Chamilos, R Ben‐Ami, ... Mycoses 56 (6), 638-645, 2013 | 255 | 2013 |
| Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers Y Angel, A Spitzer, O Henig, E Saiag, E Sprecher, H Padova, R Ben-Ami Jama 325 (24), 2457-2465, 2021 | 218 | 2021 |
| Parameters of red blood cell aggregation as correlates of the inflammatory state RB Ami, G Barshtein, D Zeltser, Y Goldberg, I Shapira, A Roth, G Keren, ... American Journal of Physiology-Heart and Circulatory Physiology 280 (5 …, 2001 | 205 | 2001 |
| Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection R Ben‐Ami, RE Lewis, DP Kontoyiannis British journal of haematology 150 (4), 406-417, 2010 | 203 | 2010 |
| Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses NA Chow, JF Muñoz, L Gade, EL Berkow, X Li, RM Welsh, K Forsberg, ... MBio 11 (2), 10.1128/mbio. 03364-19, 2020 | 200 | 2020 |
| Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection R Ben-Ami, K Olshtain-Pops, M Krieger, I Oren, J Bishara, M Dan, ... Antimicrobial agents and chemotherapy 56 (5), 2518-2523, 2012 | 188 | 2012 |
| Venous and arterial thrombosis following administration of intravenous immunoglobulins D Paran, Y Herishanu, O Elkayam, L Shopin, R Ben-Ami Blood coagulation & fibrinolysis 16 (5), 313-318, 2005 | 150 | 2005 |
| Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance R Ben-Ami, G Garcia-Effron, RE Lewis, S Gamarra, K Leventakos, ... Journal of Infectious Diseases 204 (4), 626-635, 2011 | 146 | 2011 |
| Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis GA Lamaris, R Ben-Ami, RE Lewis, G Chamilos, G Samonis, ... The Journal of infectious diseases 199 (9), 1399-1406, 2009 | 139 | 2009 |
| Safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients after allogeneic HCT or CD19-based CART therapy—a single-center prospective cohort study R Ram, D Hagin, N Kikozashvilli, T Freund, O Amit, Y Bar-On, ... Transplantation and cellular therapy 27 (9), 788-794, 2021 | 136 | 2021 |
| Phaeohyphomycosis in a tertiary care cancer center R Ben-Ami, RE Lewis, II Raad, DP Kontoyiannis Clinical infectious diseases 48 (8), 1033-1041, 2009 | 131 | 2009 |
| Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites R Ben-Ami, RE Lewis, K Leventakos, DP Kontoyiannis Blood, The Journal of the American Society of Hematology 114 (26), 5393-5399, 2009 | 127 | 2009 |
| Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial JA Maertens, G Rahav, DG Lee, A Ponce-de-León, ICR Sánchez, ... The Lancet 397 (10273), 499-509, 2021 | 123 | 2021 |
Dimitrios P. Kontoyiannis, MD, ScD, P...University of Texas MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
